— Know what they know.
Not Investment Advice

XBIT NASDAQ

XBiotech Inc.
1W: +0.9% 1M: +0.0% 3M: -9.1% YTD: -8.0% 1Y: -17.1% 3Y: -45.5% 5Y: -84.7%
$2.19
-0.01 (-0.45%)
 
Weekly Expected Move ±1.9%
$2 $2 $2 $2 $2
NASDAQ · Healthcare · Biotechnology · Tech Score Neutral · Power 38 · $66.8M mcap · 19M float · 0.195% daily turnover · Short 47% of daily vol

Supply Chain Overview

2 relationships
2
As Filer
counterparties named
0
As Counterparty
mentioned by others
1
Rel. Types
2022-02-02
Earliest Filing
2024-01-04
Latest Filing
customer: 2

Counterparties (Filed by XBIT)

2 relationships

Companies named in XBIT's SEC 8-K filings as business counterparties.

Counterparty Ticker Relationship Summary Filing Date SEC
XBiotech Inc. XBIT customer Company receiving $10M convertible loan for R&D facility construction 2024-01-04 View
Janssen Research & Development, LLC — customer XBiotech executed a manufacturing agreement to produce clinical product Bermekimab for Janssen. 2022-02-02 View
Recent 8-K Filings (15)
Filing Date Description Type SEC
2025-12-09 Departure/Election of Directors; Appointment of Officers View
2025-10-15 Departure/Election of Directors; Appointment of Officers View
2025-10-03 Entry into Material Definitive Agreement; Departure/Election of Directors; Appointment of Officers; Agreement View
2025-09-02 Submission of Matters to a Vote of Security Holders View
2025-06-24 Departure/Election of Directors; Appointment of Officers View
2025-04-07 Notice of Delisting or Transfer View
2025-04-01 Departure/Election of Directors; Appointment of Officers View
2024-12-31 Departure/Election of Directors; Appointment of Officers View
2024-06-20 Submission of Matters to a Vote of Security Holders View
2024-01-04 Entry into Material Definitive Agreement; Creation of Direct Financial Obligation; Unregistered Sale Agreement View
2023-06-23 Submission of Matters to a Vote of Security Holders View
2023-02-15 Departure/Election of Directors; Appointment of Officers View
2022-06-29 Submission of Matters to a Vote of Security Holders View
2022-02-02 Entry into Material Definitive Agreement Agreement View
2021-07-06 Other Events; Financial Statements and Exhibits View
Data extracted from SEC EDGAR 8-K filings using NLP. Relationships are as disclosed in filing text. Covers 2021–2026. View on SEC EDGAR

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms